BIOTIE THERAPIES OYJ's ticker is BITI and the CUSIP is 09074D103. A total of 19 filers reported holding BIOTIE THERAPIES OYJ in Q1 2016. The put-call ratio across all filers is - and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $206,000 | – | 7,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 268,672 | $3,516,916,000 | 2.02% |
| SPHERA FUNDS MANAGEMENT LTD. | 196,800 | $2,576,000 | 0.33% |
| Foresite Capital Management II, LLC | 80,883 | $1,059,000 | 0.32% |
| Baupost Group | 1,256,006 | $16,441,000 | 0.27% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 219,558 | $2,874,000 | 0.11% |
| Cormorant Asset Management, LP | 50,000 | $655,000 | 0.10% |
| Orbimed Advisors | 268,672 | $3,517,000 | 0.04% |
| SABBY MANAGEMENT, LLC | 40,000 | $524,000 | 0.02% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 197,300 | $2,583,000 | 0.01% |
| Tower Research Capital LLC (TRC) | 1,453 | $19,000 | 0.00% |